Literature DB >> 14749700

TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.

T Kanie1, A Abe, T Matsuda, Y Kuno, M Towatari, T Yamamoto, H Saito, N Emi, T Naoe.   

Abstract

We previously reported the fusion of the TEL gene to the Syk gene in myelodysplastic syndrome with t(9;12)(q22;p12). TEL-Syk fusion transformed interleukin-3 (IL-3)-dependent murine hematopoietic cell line BaF3 to growth factor independence. Here, we investigate the intracellular signal transduction of the stable transfectants. TEL-Syk fusion protein was associated with the p85 subunit of phosphatidyl inositol 3 kinase (PI3-K) followed by the activation of Akt in the absence of IL-3. Vav, phospholipase C-gamma2 and mitogen-activated protein kinase (MAPK) were also constitutively activated. TEL-Syk also activated the signal transducer and activator of transcription 5 (STAT5) in the absence of Janus kinase 2 activation. None of these kinases were phosphorylated in the BaF3 cells transfected with TELDeltaPNT-Syk in which the oligomerization domain of TEL was deleted. Inhibitor analysis showed that the MAPK pathway was important in TEL-Syk-mediated cell proliferation. The immunofluorescence technique revealed that the TEL-Syk fusion protein was located in the cytoplasm. These data suggest that TEL-Syk fusion protein in the cytoplasm leads to the constitutive activation of PI3-K/Akt, MAPK and STAT5 signal pathways, which are closely involved in IL-3-independent cell proliferation of BaF3 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749700     DOI: 10.1038/sj.leu.2403266

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  18 in total

1.  Establishment of a stroma-dependent human acute myelomonocytic leukemia cell line, NAMO-2, with FLT3 tandem duplication.

Authors:  Akihiro Abe; Hitoshi Kiyoi; Manabu Ninomiya; Tomio Yamazaki; Takuhei Murase; Kazutaka Ozeki; Momoko Suzuki; Fumihiko Hayakawa; Akira Katsumi; Nobuhiko Emi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

3.  HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling.

Authors:  Roland Walter; Kuan-Ting Pan; Carmen Doebele; Federico Comoglio; Katarzyna Tomska; Hanibal Bohnenberger; Ryan M Young; Laura Jacobs; Ulrich Keller; Halvard Bönig; Michael Engelke; Andreas Rosenwald; Henning Urlaub; Louis M Staudt; Hubert Serve; Thorsten Zenz; Thomas Oellerich
Journal:  Blood       Date:  2016-11-15       Impact factor: 22.113

4.  STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant.

Authors:  Megumi Funakoshi-Tago; Kenji Tago; Miyuki Abe; Yoshiko Sonoda; Tadashi Kasahara
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

5.  Syk Is Recruited to Stress Granules and Promotes Their Clearance through Autophagy.

Authors:  Mariya O Krisenko; Reneé L Higgins; Soumitra Ghosh; Qing Zhou; Joy S Trybula; Wen-Horng Wang; Robert L Geahlen
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

Review 6.  Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.

Authors:  Mariya O Krisenko; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2014-11-04

7.  In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling.

Authors:  Peter G Miller; Fatima Al-Shahrour; Kimberly A Hartwell; Lisa P Chu; Marcus Järås; Rishi V Puram; Alexandre Puissant; Kevin P Callahan; John Ashton; Marie E McConkey; Luke P Poveromo; Glenn S Cowley; Michael G Kharas; Myriam Labelle; Sebastian Shterental; Joji Fujisaki; Lev Silberstein; Gabriela Alexe; Muhammad A Al-Hajj; Christopher A Shelton; Scott A Armstrong; David E Root; David T Scadden; Richard O Hynes; Siddhartha Mukherjee; Kimberly Stegmaier; Craig T Jordan; Benjamin L Ebert
Journal:  Cancer Cell       Date:  2013-06-13       Impact factor: 31.743

8.  Proteomic and genetic approaches identify Syk as an AML target.

Authors:  Cynthia K Hahn; Jacob E Berchuck; Kenneth N Ross; Rose M Kakoza; Karl Clauser; Anna C Schinzel; Linda Ross; Ilene Galinsky; Tina N Davis; Serena J Silver; David E Root; Richard M Stone; Daniel J DeAngelo; Martin Carroll; William C Hahn; Steven A Carr; Todd R Golub; Andrew L Kung; Kimberly Stegmaier
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

Review 9.  Syk and pTyr'd: Signaling through the B cell antigen receptor.

Authors:  Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2009-03-21

10.  Differential phosphoprotein signaling in the cortex in mouse models of Gulf War Illness using corticosterone and acetylcholinesterase inhibitors.

Authors:  Julia A Penatzer; Julie V Miller; Nicole Prince; Misa Shaw; Cayla Lynch; Mackenzie Newman; Gerald R Hobbs; Jonathan W Boyd
Journal:  Heliyon       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.